nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—Zopiclone—CYP2E1—Parkinson's disease	0.0201	1	CrCbGaD
Eszopiclone—GABRB2—hindbrain—Parkinson's disease	0.0124	0.0347	CbGeAlD
Eszopiclone—GABRA2—hindbrain—Parkinson's disease	0.0113	0.0317	CbGeAlD
Eszopiclone—GABRA1—hindbrain—Parkinson's disease	0.011	0.0306	CbGeAlD
Eszopiclone—GABRA5—forebrain—Parkinson's disease	0.00904	0.0253	CbGeAlD
Eszopiclone—GABRA4—forebrain—Parkinson's disease	0.0082	0.0229	CbGeAlD
Eszopiclone—GABRB2—brainstem—Parkinson's disease	0.00711	0.0199	CbGeAlD
Eszopiclone—GABRG2—forebrain—Parkinson's disease	0.00686	0.0192	CbGeAlD
Eszopiclone—GABRB2—forebrain—Parkinson's disease	0.00686	0.0192	CbGeAlD
Eszopiclone—GABRG3—head—Parkinson's disease	0.00674	0.0188	CbGeAlD
Eszopiclone—TSPO—embryo—Parkinson's disease	0.00656	0.0183	CbGeAlD
Eszopiclone—GABRA2—brainstem—Parkinson's disease	0.0065	0.0181	CbGeAlD
Eszopiclone—GABRG3—nervous system—Parkinson's disease	0.00639	0.0178	CbGeAlD
Eszopiclone—GABRA1—brainstem—Parkinson's disease	0.00628	0.0175	CbGeAlD
Eszopiclone—GABRA2—forebrain—Parkinson's disease	0.00627	0.0175	CbGeAlD
Eszopiclone—GABRG3—central nervous system—Parkinson's disease	0.00615	0.0172	CbGeAlD
Eszopiclone—GABRA1—forebrain—Parkinson's disease	0.00606	0.0169	CbGeAlD
Eszopiclone—TSPO—brainstem—Parkinson's disease	0.00601	0.0168	CbGeAlD
Eszopiclone—TSPO—forebrain—Parkinson's disease	0.0058	0.0162	CbGeAlD
Eszopiclone—GABRA5—head—Parkinson's disease	0.00518	0.0145	CbGeAlD
Eszopiclone—GABRG2—medulla oblongata—Parkinson's disease	0.00496	0.0139	CbGeAlD
Eszopiclone—GABRB2—medulla oblongata—Parkinson's disease	0.00496	0.0139	CbGeAlD
Eszopiclone—GABRA5—nervous system—Parkinson's disease	0.00491	0.0137	CbGeAlD
Eszopiclone—TSPO—cardiovascular system—Parkinson's disease	0.00491	0.0137	CbGeAlD
Eszopiclone—GABRG3—brain—Parkinson's disease	0.00488	0.0136	CbGeAlD
Eszopiclone—GABRA3—head—Parkinson's disease	0.00482	0.0135	CbGeAlD
Eszopiclone—GABRA5—central nervous system—Parkinson's disease	0.00473	0.0132	CbGeAlD
Eszopiclone—GABRA4—head—Parkinson's disease	0.0047	0.0131	CbGeAlD
Eszopiclone—GABRA3—nervous system—Parkinson's disease	0.00457	0.0128	CbGeAlD
Eszopiclone—GABRB2—midbrain—Parkinson's disease	0.00453	0.0127	CbGeAlD
Eszopiclone—GABRG2—midbrain—Parkinson's disease	0.00453	0.0127	CbGeAlD
Eszopiclone—GABRA4—nervous system—Parkinson's disease	0.00445	0.0124	CbGeAlD
Eszopiclone—GABRG2—spinal cord—Parkinson's disease	0.00442	0.0124	CbGeAlD
Eszopiclone—GABRB2—spinal cord—Parkinson's disease	0.00442	0.0124	CbGeAlD
Eszopiclone—GABRA3—central nervous system—Parkinson's disease	0.0044	0.0123	CbGeAlD
Eszopiclone—GABRA1—medulla oblongata—Parkinson's disease	0.00438	0.0122	CbGeAlD
Eszopiclone—GABRA4—central nervous system—Parkinson's disease	0.00429	0.012	CbGeAlD
Eszopiclone—TSPO—medulla oblongata—Parkinson's disease	0.00419	0.0117	CbGeAlD
Eszopiclone—GABRA4—cerebellum—Parkinson's disease	0.00419	0.0117	CbGeAlD
Eszopiclone—GABRA1—midbrain—Parkinson's disease	0.004	0.0112	CbGeAlD
Eszopiclone—GABRG2—head—Parkinson's disease	0.00393	0.011	CbGeAlD
Eszopiclone—GABRB2—head—Parkinson's disease	0.00393	0.011	CbGeAlD
Eszopiclone—GABRA1—spinal cord—Parkinson's disease	0.0039	0.0109	CbGeAlD
Eszopiclone—TSPO—midbrain—Parkinson's disease	0.00383	0.0107	CbGeAlD
Eszopiclone—GABRA5—brain—Parkinson's disease	0.00375	0.0105	CbGeAlD
Eszopiclone—TSPO—spinal cord—Parkinson's disease	0.00374	0.0104	CbGeAlD
Eszopiclone—GABRG2—nervous system—Parkinson's disease	0.00373	0.0104	CbGeAlD
Eszopiclone—GABRB2—nervous system—Parkinson's disease	0.00373	0.0104	CbGeAlD
Eszopiclone—GABRA2—head—Parkinson's disease	0.00359	0.01	CbGeAlD
Eszopiclone—GABRG2—central nervous system—Parkinson's disease	0.00359	0.01	CbGeAlD
Eszopiclone—GABRB2—central nervous system—Parkinson's disease	0.00359	0.01	CbGeAlD
Eszopiclone—GABRG2—cerebellum—Parkinson's disease	0.00351	0.00979	CbGeAlD
Eszopiclone—GABRB2—cerebellum—Parkinson's disease	0.00351	0.00979	CbGeAlD
Eszopiclone—GABRA3—brain—Parkinson's disease	0.00349	0.00976	CbGeAlD
Eszopiclone—GABRA1—head—Parkinson's disease	0.00347	0.00969	CbGeAlD
Eszopiclone—GABRA4—brain—Parkinson's disease	0.0034	0.00951	CbGeAlD
Eszopiclone—GABRA2—nervous system—Parkinson's disease	0.0034	0.00951	CbGeAlD
Eszopiclone—TSPO—head—Parkinson's disease	0.00332	0.00928	CbGeAlD
Eszopiclone—GABRA1—nervous system—Parkinson's disease	0.00329	0.00919	CbGeAlD
Eszopiclone—GABRA2—central nervous system—Parkinson's disease	0.00328	0.00915	CbGeAlD
Eszopiclone—PTGS1—forebrain—Parkinson's disease	0.00323	0.00902	CbGeAlD
Eszopiclone—GABRA2—cerebellum—Parkinson's disease	0.0032	0.00895	CbGeAlD
Eszopiclone—GABRA1—central nervous system—Parkinson's disease	0.00317	0.00885	CbGeAlD
Eszopiclone—TSPO—nervous system—Parkinson's disease	0.00315	0.0088	CbGeAlD
Eszopiclone—GABRA1—cerebellum—Parkinson's disease	0.0031	0.00865	CbGeAlD
Eszopiclone—TSPO—central nervous system—Parkinson's disease	0.00303	0.00848	CbGeAlD
Eszopiclone—CYP2C9—cardiovascular system—Parkinson's disease	0.00299	0.00836	CbGeAlD
Eszopiclone—TSPO—cerebellum—Parkinson's disease	0.00297	0.00828	CbGeAlD
Eszopiclone—GABRB2—brain—Parkinson's disease	0.00285	0.00796	CbGeAlD
Eszopiclone—GABRG2—brain—Parkinson's disease	0.00285	0.00796	CbGeAlD
Eszopiclone—PTGS1—cardiovascular system—Parkinson's disease	0.00273	0.00763	CbGeAlD
Eszopiclone—GABRA2—brain—Parkinson's disease	0.0026	0.00727	CbGeAlD
Eszopiclone—GABRA1—brain—Parkinson's disease	0.00251	0.00702	CbGeAlD
Eszopiclone—TSPO—brain—Parkinson's disease	0.00241	0.00673	CbGeAlD
Eszopiclone—PTGS1—spinal cord—Parkinson's disease	0.00208	0.00581	CbGeAlD
Eszopiclone—PTGS1—head—Parkinson's disease	0.00185	0.00517	CbGeAlD
Eszopiclone—PTGS1—nervous system—Parkinson's disease	0.00175	0.0049	CbGeAlD
Eszopiclone—PTGS1—central nervous system—Parkinson's disease	0.00169	0.00472	CbGeAlD
Eszopiclone—CYP2C8—brain—Parkinson's disease	0.00165	0.00462	CbGeAlD
Eszopiclone—CYP3A4—nervous system—Parkinson's disease	0.00146	0.00409	CbGeAlD
Eszopiclone—CYP3A4—central nervous system—Parkinson's disease	0.00141	0.00394	CbGeAlD
Eszopiclone—PTGS1—brain—Parkinson's disease	0.00134	0.00374	CbGeAlD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000555	0.000893	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000555	0.000893	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—COMT—Parkinson's disease	0.000553	0.000888	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—GSTP1—Parkinson's disease	0.00055	0.000884	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000549	0.000883	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—MAOA—Parkinson's disease	0.000549	0.000882	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000548	0.000881	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000546	0.000877	CbGpPWpGaD
Eszopiclone—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000543	0.000873	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000543	0.000872	CbGpPWpGaD
Eszopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000537	0.000863	CbGpPWpGaD
Eszopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00053	0.000852	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—COMT—Parkinson's disease	0.000527	0.000847	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—MAOA—Parkinson's disease	0.000523	0.000841	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000516	0.000829	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.000514	0.000826	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—COMT—Parkinson's disease	0.000512	0.000823	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000511	0.000822	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—MAOA—Parkinson's disease	0.000508	0.000817	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000508	0.000816	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—GSTM1—Parkinson's disease	0.000505	0.000813	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—COMT—Parkinson's disease	0.000502	0.000808	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000502	0.000808	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—MAOA—Parkinson's disease	0.000499	0.000802	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.000495	0.000796	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—COMT—Parkinson's disease	0.000494	0.000794	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000493	0.000793	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—MAOA—Parkinson's disease	0.00049	0.000788	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000484	0.000779	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—COMT—Parkinson's disease	0.000482	0.000774	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—MAOA—Parkinson's disease	0.000478	0.000769	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000476	0.000765	CbGpPWpGaD
Eszopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000476	0.000765	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—CYP2D6—Parkinson's disease	0.000471	0.000757	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000467	0.000751	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000464	0.000747	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000464	0.000747	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000454	0.00073	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000453	0.000729	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000446	0.000717	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000438	0.000704	CbGpPWpGaD
Eszopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000435	0.0007	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—CYP2E1—Parkinson's disease	0.000431	0.000693	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000427	0.000687	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000425	0.000683	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—COMT—Parkinson's disease	0.000421	0.000677	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.000418	0.000672	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000406	0.000653	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000396	0.000636	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000394	0.000633	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000383	0.000616	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000382	0.000614	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000381	0.000612	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00038	0.000611	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000378	0.000608	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000376	0.000605	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000374	0.000601	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000364	0.000585	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ND3—Parkinson's disease	0.000358	0.000576	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—MCCC1—Parkinson's disease	0.000358	0.000576	CbGpPWpGaD
Eszopiclone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000358	0.000576	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—COMT—Parkinson's disease	0.000357	0.000574	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—GSTP1—Parkinson's disease	0.000355	0.000571	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—MAOA—Parkinson's disease	0.000354	0.00057	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—COMT—Parkinson's disease	0.000352	0.000566	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000351	0.000564	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00035	0.000563	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00035	0.000562	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000346	0.000556	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00034	0.000547	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—OMD—Parkinson's disease	0.000337	0.000542	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—TALDO1—Parkinson's disease	0.000337	0.000542	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000333	0.000535	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00033	0.000531	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000329	0.000529	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—GSTM1—Parkinson's disease	0.000326	0.000525	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000323	0.00052	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000322	0.000518	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000322	0.000517	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000321	0.000516	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000321	0.000515	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00032	0.000514	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NDUFB11—Parkinson's disease	0.000319	0.000513	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000318	0.000511	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000317	0.00051	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000312	0.000502	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000311	0.000499	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000305	0.00049	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GCH1—Parkinson's disease	0.000305	0.00049	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000305	0.00049	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000304	0.000489	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.0003	0.000482	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000292	0.00047	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000292	0.000469	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.00029	0.000467	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000289	0.000465	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000288	0.000464	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000286	0.000461	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000285	0.000458	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000278	0.000447	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000275	0.000442	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—DBH—Parkinson's disease	0.000272	0.000437	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—FBP1—Parkinson's disease	0.000272	0.000437	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GBA—Parkinson's disease	0.000272	0.000437	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00027	0.000434	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000267	0.000429	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000266	0.000428	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000266	0.000427	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000265	0.000427	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000265	0.000426	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000262	0.000421	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000261	0.000419	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000259	0.000417	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000256	0.000411	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000254	0.000409	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000254	0.000409	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000253	0.000406	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00025	0.000402	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000249	0.000401	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000246	0.000395	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000244	0.000392	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000233	0.000375	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MCCC1—Parkinson's disease	0.000231	0.000372	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ND3—Parkinson's disease	0.000231	0.000372	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000231	0.000372	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000228	0.000367	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000222	0.000357	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—TALDO1—Parkinson's disease	0.000218	0.00035	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—OMD—Parkinson's disease	0.000218	0.00035	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000213	0.000343	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	0.000206	0.000332	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.0002	0.000322	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—DDC—Parkinson's disease	0.000199	0.00032	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GCH1—Parkinson's disease	0.000197	0.000316	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000192	0.000308	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000191	0.000307	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.00019	0.000306	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000189	0.000304	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.000188	0.000303	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ND3—Parkinson's disease	0.000188	0.000303	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000188	0.000303	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTA4—Parkinson's disease	0.000188	0.000303	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000188	0.000302	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000186	0.000299	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000177	0.000285	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.000177	0.000285	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—OMD—Parkinson's disease	0.000177	0.000285	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GBA—Parkinson's disease	0.000175	0.000282	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—FBP1—Parkinson's disease	0.000175	0.000282	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—DBH—Parkinson's disease	0.000175	0.000282	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000175	0.000282	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000173	0.000278	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PLA2G6—Parkinson's disease	0.000169	0.000272	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.000168	0.00027	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—MAOB—Parkinson's disease	0.000168	0.00027	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.00016	0.000258	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00016	0.000257	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000144	0.000232	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GBA—Parkinson's disease	0.000143	0.00023	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—DBH—Parkinson's disease	0.000143	0.00023	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.000143	0.00023	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—DDC—Parkinson's disease	0.000129	0.000207	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP2D6—Parkinson's disease	0.000125	0.0002	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000124	0.0002	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000124	0.0002	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CTGF—Parkinson's disease	0.000122	0.000197	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTA4—Parkinson's disease	0.000122	0.000195	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00012	0.000193	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000117	0.000188	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000117	0.000188	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP2E1—Parkinson's disease	0.000114	0.000183	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NQO1—Parkinson's disease	0.000113	0.000181	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—TH—Parkinson's disease	0.000111	0.000179	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000111	0.000178	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	0.000109	0.000176	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MAOB—Parkinson's disease	0.000108	0.000174	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYCS—Parkinson's disease	0.000107	0.000172	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000106	0.00017	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—DDC—Parkinson's disease	0.000105	0.000168	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000103	0.000166	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTA4—Parkinson's disease	9.89e-05	0.000159	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	9.77e-05	0.000157	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—COMT—Parkinson's disease	9.45e-05	0.000152	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—FBP1—Parkinson's disease	9.41e-05	0.000151	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—DBH—Parkinson's disease	9.41e-05	0.000151	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GBA—Parkinson's disease	9.41e-05	0.000151	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTP1—Parkinson's disease	9.4e-05	0.000151	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—MAOA—Parkinson's disease	9.38e-05	0.000151	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—HMOX1—Parkinson's disease	9.27e-05	0.000149	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	8.91e-05	0.000143	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ABCB1—Parkinson's disease	8.9e-05	0.000143	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MAOB—Parkinson's disease	8.82e-05	0.000142	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTM1—Parkinson's disease	8.64e-05	0.000139	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	8.39e-05	0.000135	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GPX1—Parkinson's disease	8.28e-05	0.000133	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	8.05e-05	0.000129	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CTGF—Parkinson's disease	7.9e-05	0.000127	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—MTHFR—Parkinson's disease	7.64e-05	0.000123	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	7.37e-05	0.000118	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NQO1—Parkinson's disease	7.28e-05	0.000117	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—TH—Parkinson's disease	7.18e-05	0.000115	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—APOE—Parkinson's disease	7.11e-05	0.000114	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—DDC—Parkinson's disease	6.91e-05	0.000111	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYCS—Parkinson's disease	6.89e-05	0.000111	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	6.55e-05	0.000105	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTA4—Parkinson's disease	6.53e-05	0.000105	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CTGF—Parkinson's disease	6.43e-05	0.000103	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—COMT—Parkinson's disease	6.1e-05	9.81e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTP1—Parkinson's disease	6.07e-05	9.77e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—INS—Parkinson's disease	6.07e-05	9.77e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MAOA—Parkinson's disease	6.06e-05	9.74e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	5.99e-05	9.64e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HMOX1—Parkinson's disease	5.99e-05	9.63e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NQO1—Parkinson's disease	5.93e-05	9.53e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	5.88e-05	9.45e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—TH—Parkinson's disease	5.84e-05	9.39e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MAOB—Parkinson's disease	5.82e-05	9.35e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ABCB1—Parkinson's disease	5.75e-05	9.25e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYCS—Parkinson's disease	5.61e-05	9.02e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTM1—Parkinson's disease	5.58e-05	8.98e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GPX1—Parkinson's disease	5.35e-05	8.6e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—COMT—Parkinson's disease	4.97e-05	7.99e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTP1—Parkinson's disease	4.94e-05	7.95e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MTHFR—Parkinson's disease	4.93e-05	7.93e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MAOA—Parkinson's disease	4.93e-05	7.93e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HMOX1—Parkinson's disease	4.88e-05	7.84e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ABCB1—Parkinson's disease	4.68e-05	7.52e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—APOE—Parkinson's disease	4.59e-05	7.38e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTM1—Parkinson's disease	4.54e-05	7.3e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GPX1—Parkinson's disease	4.35e-05	7e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	4.32e-05	6.95e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CTGF—Parkinson's disease	4.24e-05	6.82e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MTHFR—Parkinson's disease	4.02e-05	6.46e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.95e-05	6.36e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—INS—Parkinson's disease	3.92e-05	6.31e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.91e-05	6.29e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—TH—Parkinson's disease	3.85e-05	6.19e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—APOE—Parkinson's disease	3.74e-05	6.01e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.7e-05	5.95e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—COMT—Parkinson's disease	3.28e-05	5.27e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.26e-05	5.24e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.25e-05	5.23e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3.22e-05	5.17e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—INS—Parkinson's disease	3.19e-05	5.13e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ABCB1—Parkinson's disease	3.09e-05	4.96e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTM1—Parkinson's disease	3e-05	4.82e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.87e-05	4.61e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.65e-05	4.26e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—APOE—Parkinson's disease	2.47e-05	3.96e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—INS—Parkinson's disease	2.11e-05	3.39e-05	CbGpPWpGaD
